Patents by Inventor Won-Jin Yun

Won-Jin Yun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240098275
    Abstract: A method for decoding an image based on an intra prediction, comprising: obtaining a first prediction pixel of a first region in a current block by using a neighboring pixel adjacent to the current block; obtaining a second prediction pixel of a second region in the current block by using the first prediction pixel of the first region; and decoding the current block based on the first and the second prediction pixels.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 21, 2024
    Inventors: Je Chang JEONG, Ki Baek KIM, Won Jin LEE, Hye Jin SHIN, Jong Sang YOO, Jang Hyeok YUN, Kyung Jun LEE, Jae Hun KIM, Sang Gu LEE
  • Patent number: 11572540
    Abstract: Provided is a method of inducing oligodendrocyte precursor cells (OPCs) through direct reprogramming from human somatic cells into which a nucleic acid molecule encoding an Oct4 protein or Oct4 protein-treated human somatic cells. The method of inducing OPCs by treating Oct4-overexpressing human somatic cells with a low molecular weight substance may establish OPCs with high efficiency in a short period of time through direct reprogramming without via neural stem cells, and thus the OPCs are useful as a cell therapeutic agent for an intractable demyelinating disease.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: February 7, 2023
    Assignee: Stemlab Inc.
    Inventors: Seung Kwon You, Won-Jin Yun, Min Ji Park, Ji-Yong Park
  • Publication number: 20220177851
    Abstract: Disclosed is a method for inducing direct reprogramming of urine cells into renal progenitor cells and a pharmaceutical composition including the renal progenitor cells reprogrammed by the method for preventing or treating renal cell injury disease. The method can make the mass production of customized reprogrammed renal progenitor cells by using urine cells, which are somatic cells easily and repeatedly obtainable without inconvenience and pain and as such, can be applied to incurable disease fields expandable to the renal injury therapy and kidney regeneration fields and to the production of cell therapy products.
    Type: Application
    Filed: April 9, 2020
    Publication date: June 9, 2022
    Inventors: Seung Kwon YOU, In Yong KIM, Wei Wei GAO, Phil Jun KANG, Won-Jin YUN, Gyuman PARK
  • Publication number: 20210260132
    Abstract: A method for inducing reprogramming of neural stem cells from urine cells by introducing mRNAs of reprogramming factors Oct4, Sox2, Klf4, and Glis1 is disclosed. A composition for the prevention or treatment of neurological damage diseases with the neural stem cells induced by the method as an active ingredient is disclosed.
    Type: Application
    Filed: August 28, 2019
    Publication date: August 26, 2021
    Inventors: Seung Kwon YOU, Phil Jun KANG, Da Ryeon SON, Won Jun HONG, Won Jin YUN, Jang Bo LEE, Gyu Man PARK, In Yong KIM, Jung Hyun PARK, Jie ZHENG, Wei Wei GAO, Ji Hoon JANG, Eun Kyoung JUN, Byung Sun YOON
  • Publication number: 20210017491
    Abstract: Provided is a method of inducing oligodendrocyte precursor cells (OPCs) through direct reprogramming from human somatic cells into which a nucleic acid molecule encoding an Oct4 protein or Oct4 protein-treated human somatic cells. The method of inducing OPCs by treating Oct4-overexpressing human somatic cells with a low molecular weight substance may establish OPCs with high efficiency in a short period of time through direct reprogramming without via neural stem cells, and thus the OPCs are useful as a cell therapeutic agent for an intractable demyelinating disease.
    Type: Application
    Filed: August 13, 2020
    Publication date: January 21, 2021
    Applicant: Stemlab Inc.
    Inventors: Seung Kwon YOU, Won-Jin YUN, Min Ji PARK, Ji-Yong PARK
  • Patent number: 10767163
    Abstract: Provided is a method of inducing oligodendrocyte precursor cells (OPCs) through direct reprogramming from human somatic cells into which a nucleic acid molecule encoding an Oct4 protein or Oct4 protein-treated human somatic cells. The method of inducing OPCs by treating Oct4-overexpressing human somatic cells with a low molecular weight substance may establish OPCs with high efficiency in a short period of time through direct reprogramming without via neural stem cells, and thus the OPCs are useful as a cell therapeutic agent for an intractable demyelinating disease.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: September 8, 2020
    Assignee: Stemlab Inc.
    Inventors: Seung Kwon You, Won Jin Yun, Min Ji Park, Ji Yong Park
  • Patent number: 10640541
    Abstract: The present invention relates to a culture solution of MSCs derived from a fetus in amniotic fluid, and more specifically, to a composition for promoting hair growth or preventing hair loss, which includes a culture solution of MSCs overexpressing a reprogramming factor Nanog and derived from a fetus in amniotic fluid as an active ingredient. In addition, the present invention relates to a method for preparing the composition, which includes culturing Nanog-introduced MSCs derived from a fetus in amniotic fluid in a conditioned medium and collecting the culture solution. The conditioned medium composition according to the present invention exhibits a hair growth promoting effect, and thus is able to be used as cosmetic and pharmaceutical compositions for promoting hair growth.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: May 5, 2020
    Assignee: Stemlab Inc.
    Inventors: Seung Kwon You, Eun Kyoung Jun, Jung Hyun Park, Won-Jin Yun, Da-Ryeon Son
  • Publication number: 20190284528
    Abstract: Provided is a method of inducing oligodendrocyte precursor cells (OPCs) through direct reprogramming from human somatic cells into which a nucleic acid molecule encoding an Oct4 protein or Oct4 protein-treated human somatic cells. The method of inducing OPCs by treating Oct4-overexpressing human somatic cells with a low molecular weight substance may establish OPCs with high efficiency in a short period of time through direct reprogramming without via neural stem cells, and thus the OPCs are useful as a cell therapeutic agent for an intractable demyelinating disease.
    Type: Application
    Filed: June 3, 2019
    Publication date: September 19, 2019
    Applicant: Stemlab Inc.
    Inventors: Seung Kwon YOU, Won Jin YUN, Min Ji PARK, Ji Yong PARK
  • Publication number: 20180362606
    Abstract: The present invention relates to a culture solution of MSCs derived from a fetus in amniotic fluid, and more specifically, to a composition for promoting hair growth or preventing hair loss, which includes a culture solution of MSCs overexpressing a reprogramming factor Nanog and derived from a fetus in amniotic fluid as an active ingredient. In addition, the present invention relates to a method for preparing the composition, which includes culturing Nanog-introduced MSCs derived from a fetus in amniotic fluid in a conditioned medium and collecting the culture solution. The conditioned medium composition according to the present invention exhibits a hair growth promoting effect, and thus is able to be used as cosmetic and pharmaceutical compositions for promoting hair growth.
    Type: Application
    Filed: September 9, 2016
    Publication date: December 20, 2018
    Inventors: Seung Kwon YOU, Eun Kyoung JUN, Jung Hyun PARK, Won-Jin YUN, Da-Ryeon SON
  • Publication number: 20180155685
    Abstract: Provided is a method of inducing oligodendrocyte precursor cells (OPCS) through direct reprogramming from human somatic cells into which a nucleic acid molecule encoding an Oct4 protein or Oct4 protein-treated human somatic cells. The method of inducing OPCs by treating Oct4-overexpressing human somatic cells with a low molecular weight substance may establish OPCs with high efficiency in a short period of time through direct reprogramming without via neural stem cells, and thus the OPCs are useful as a cell therapeutic agent for an intractable demyelinating disease.
    Type: Application
    Filed: May 2, 2016
    Publication date: June 7, 2018
    Inventors: Seung Kwon YOU, Won-Jin YUN, Min Ji PARK, Ji-Yong PARK
  • Publication number: 20090240552
    Abstract: The invention relates to a network-based information technology solution development and management system and method. In the system and method according to an embodiment of the invention, when a customer requests the development of information technology solutions, a server computer provides information on analysts to a customer computer and allows the customer to contract with a specific analyst. Then, the analyst receives requirements for the development of the solutions from the customer to perform the planning of the solutions, the analysis of the requirements, and the design of the solutions, and then the server computer places an order for each unit program to developers. Subsequently, when the developers who have assigned the unit programs develop the unit programs and deliver the developed unit programs to the server computer, the server computer tests the unit programs to accept or return the unit programs.
    Type: Application
    Filed: April 23, 2007
    Publication date: September 24, 2009
    Applicant: DMD CO., LTD.
    Inventors: Hae-In Yang, Won-Jin Yun